Walmart Resolves DOJ Lawsuit Over Opioid Dispensing

Walmart has reached a settlement with the U.S. Department of Justice (DOJ) to resolve a long-running lawsuit regarding the company's pharmacy practices. The legal action alleged that Walmart contributed to the national opioid epidemic by failing to properly regulate how prescriptions were filled.

The DOJ claimed that Walmart pharmacies violated the federal Controlled Substances Act. Specifically, the government argued that the retailer failed to report suspicious prescription patterns to the Drug Enforcement Administration (DEA) and ignored clear warning signs. The lawsuit, which was originally filed in December 2020, suggested that the company knowingly dispensed invalid prescriptions dating back to 2013.

While both the DOJ and Walmart confirmed the agreement on Friday, the specific financial terms and conditions of the settlement were not made public. In an official statement, the DOJ emphasized its commitment to holding companies and individuals accountable for unlawful prescribing and distributing practices that put American communities at risk.

This agreement follows a separate, larger $3.1 billion settlement Walmart reached nearly four years ago to resolve claims brought by various state and local governments. Walmart is not alone in these legal challenges; other major pharmacy chains, including CVS and Walgreens, have also reached multi-billion-dollar settlements over similar allegations.

The legal battles highlight the severity of the opioid crisis in the United States. According to data from the Centers for Disease Control and Prevention (CDC), more than 905,000 people died from opioid overdoses between 1999 and 2025.

In response to the settlement, Walmart stated that it was pleased to resolve the matter. The company added that it continues to support the work of its pharmacists in providing quality care to their patients.

Share this article...